Search
Sanofi Reintroduces Quadrivalent Influenza Vaccine in China
3 week ago /
Read about 0 minute
Author：小编
Sanofi China has announced that its quadrivalent influenza virus split vaccine, tailored for the 2025-2026 flu season, has received approval and clearance from the National Medical Products Administration, marking its return to the Chinese market. This vaccine, effective in preventing various influenza virus infections, had previously been temporarily withdrawn due to potency concerns.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
